UPB - Upstream Bio, Inc.
7.37
0.970 13.161%
Share volume: 303,708
Last Updated: 04-11-2025
Pharmaceutical Products/Pharmaceutical Preparations:
0.14%
PREVIOUS CLOSE
CHG
CHG%
$6.40
0.97
0.15%
Summary score
18%
Profitability
0%
Dept financing
50%
Liquidity
50%
Performance
20%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-8.12%
Return on sales
-3112.52%
Return on invested capital
0%
Total debt ratio
168.89%
Debt ratio change over timeo
0%
Current Ratio
20.9%
Quick Ratio
0%
Cash Position Ratio
3.03%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-8.12%
Return on sales
-3112.52%
Return on invested capital
0%
Total debt ratio
168.89%
Debt ratio change over timeo
0%
Current Ratio
20.9%
Quick Ratio
0%
Cash Position Ratio
3.03%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-8.12%
Return on sales
-3112.52%
Return on invested capital
0%
Total debt ratio
168.89%
Debt ratio change over time
0%
Current Ratio
20.9%
Quick Ratio
0%
Cash Position Ratio
3.03%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
Long-term ratios | UPB | LLY | NVO | NONOF |
---|---|---|---|---|
Return on equity | 0% | 18.83% | 17.34% | 0% |
Return on assets | -8.12% | 4.14% | 8.21% | 0% |
Return on sales | -3112.52% | 27.93% | 41.18% | 0% |
Return on invested capital | 0% | 9.79% | -219.55% | 0% |
Profitability | 0% | 80% | 73% | 0% |
Total debt ratio | 168.89% | 82.52% | 55.88% | 0% |
Debt ratio change over time | 0% | -13.08% | -0.73% | 0% |
Dept financing | 50% | 12% | 8% | 0% |
Current Ratio | 20.9% | 1.13% | 0% | 0% |
Quick Ratio | 0% | 0.87% | 0% | 0% |
Cash Position Ratio | 3.03% | 0.12% | 0% | 0% |
Liquididy | 50% | 28% | 27% | 0% |
Short-term ratios | UPB | LLY | NVO | NONOF |
---|---|---|---|---|
Return on equity | 0% | 13.31% | 0% | 0% |
Return on assets | -8.12% | 4.46% | 0% | 0% |
Return on sales | -3112.52% | 29.96% | 0% | 0% |
Return on invested capital | 0% | 10.68% | 0% | 0% |
Profitability | 0% | 100% | 0% | 0% |
Total debt ratio | 168.89% | 81.12% | 0% | 0% |
Debt ratio change over time | 0% | -58.72% | 0% | 0% |
Dept financing | 50% | 12% | 0% | 0% |
Current Ratio | 20.9% | 1.13% | 0% | 0% |
Quick Ratio | 0% | 0.87% | 0% | 0% |
Cash Position Ratio | 3.03% | 0.12% | 0% | 0% |
Liquididy | 50% | 27% | 0% | 0% |